ASP Isotopes Inc. (NASDAQ:ASPI) Short Interest Update
ASP Isotopes Inc. (NASDAQ:ASPI) experienced a significant 23.0% increase in short interest in July, reaching 6,730,000 shares. Approximately 19.1% of its stock is sold short with a days-to-cover ratio of 6.0 based on an average trading volume of 1,120,000 shares. Institutional investors have increased their positions, with Vanguard raising its stake by 479.1%. The company is involved in the production of isotopes for the medical industry, including Molybdenum-100 and Carbon-14.
ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) was the target of a significant growth in short interest in the month of July. As of July 31st, there was short interest totalling 6,730,000 shares, a growth of 23.0% from the July 15th total of 5,470,000 shares. Currently, 19.1% of the shares of the company are sold short. Based on an average daily volume of 1,120,000 shares, the short-interest ratio is currently 6.0 days.
ASP Isotopes Trading Up 1.9 %
Shares of NASDAQ:ASPI opened at $2.15 on Thursday. ASP Isotopes has a 12-month low of $0.84 and a 12-month high of $5.67. The stock has a market cap of $111.29 million, a PE ratio of -4.06 and a beta of 5.16. The business has a 50 day moving average of $3.12 and a 200-day moving average of $3.53. The company has a quick ratio of 3.57, a current ratio of 3.57 and a debt-to-equity ratio of 1.70.
ASP Isotopes (NASDAQ:ASPI - Get Free Report) last issued its quarterly earnings data on Wednesday, May 15th. The company reported ($0.16) earnings per share (EPS) for the quarter. The firm had revenue of $0.84 million during the quarter. As a group, equities research analysts forecast that ASP Isotopes will post -0.11 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright reduced their price target on ASP Isotopes from $5.50 to $4.50 and set a "buy" rating for the company in a report on Wednesday, August 7th.
View Our Latest Stock Report on ASPI
Insider Buying and Selling
In other ASP Isotopes news, major shareholder Ak Jensen Investment Managemen purchased 61,849 shares of ASP Isotopes stock in a transaction that occurred on Wednesday, July 10th. The stock was acquired at an average price of $3.40 per share, for a total transaction of $210,286.60. Following the completion of the acquisition, the insider now owns 6,678,723 shares of the company's stock, valued at approximately $22,707,658.20. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 26.30% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On ASP Isotopes
A number of institutional investors have recently made changes to their positions in the company. HTLF Bank acquired a new stake in shares of ASP Isotopes in the fourth quarter valued at approximately $141,000. Rathbones Group PLC acquired a new stake in shares of ASP Isotopes in the fourth quarter valued at approximately $272,000. Vanguard Group Inc. raised its position in shares of ASP Isotopes by 479.1% in the first quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company's stock valued at $4,217,000 after buying an additional 844,705 shares in the last quarter. Virtu Financial LLC raised its position in shares of ASP Isotopes by 477.0% in the first quarter. Virtu Financial LLC now owns 83,677 shares of the company's stock valued at $346,000 after buying an additional 69,176 shares in the last quarter. Finally, Bank of New York Mellon Corp acquired a new stake in shares of ASP Isotopes in the second quarter valued at approximately $381,000. Institutional investors own 16.80% of the company's stock.
ASP Isotopes Company Profile
(Get Free Report)ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
Further Reading
- Five stocks we like better than ASP Isotopes
- Buy P&G Now, Before It Sets A New All-Time High
- Unlocking Growth: Why Arcos Dorados Belongs in Your Portfolio
- Why Are These Companies Considered Blue Chips?
- Forget Robotaxis: Electric Air Taxis are the Next Big Investment
- Most active stocks: Dollar volume vs share volume
- Crocs Stock Slips After Earnings Beat: Will It Bounce Back?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
→ Recession-proof stocks? (From Stansberry Research) (Ad)
Should you invest $1,000 in ASP Isotopes right now?
Before you consider ASP Isotopes, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ASP Isotopes wasn't on the list.
While ASP Isotopes currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
